Skip to main content

Year: 2026

Symra Beats Start-Up Schedule, DNO Boosts North Sea Output

Oslo, 7 April 2026 – DNO ASA, the Norwegian oil and gas operator, today announced the start-up of the Symra field offshore Norway nine months ahead of schedule. DNO has a 20 percent stake in the field, which is operated by Aker BP ASA (50 percent), with Equinor Energy AS holding the balance. Symra holds estimated gross reserves of 60 million barrels of oil equivalent and is expected to deliver 4,000–5,000 barrels of oil equivalent per day (boepd) net to DNO at plateau. The partnership sees significant additional resource potential that may be realized through further drilling. The development includes four wells tied back via a subsea template to the Aker BP-operated Ivar Aasen platform, in which DNO holds a 12.3 percent interest. The field breaks new ground as the first on the Norwegian Continental Shelf to produce from the Zechstein...

Continue reading

Kiniero Quarter 1 Production Update

HighlightsKiniero Gold Mine, Guinea, milled 1.6M tonnes of ore at an average grade of 0.85g/t Au to produce 39,367oz Au in Q1 CY2026. Cash and bullion increased to US$255 million (unaudited; with bullion comprising poured but unsold gold valued at a spot price of US$4,629/oz) at 31 March 2026. Kiniero poured 38,178oz Au and sold/provisionally sold 32,306oz Au at an average price of US$4,804/oz in Q1. A further 3,288oz Au was shipped on 2 April 2026 for estimated proceeds of US$15.2 million. Kiniero operation continues to ramp up following achievement of commercial production in February 2026. Nampala Gold Mine, Mali, milled 0.5M tonnes of ore at an average grade of 0.70g/t Au to produce 10,000oz Au in Q1 CY2026. Nampala poured 10,874oz Au and sold/provisionally sold 9,493oz Au at an average price of US$4,797/oz in Q1.Figure 1: Robex...

Continue reading

Himax Technologies, Inc. Schedules First Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026 at 8:00 AM EDT

TAINAN, Taiwan, April 07, 2026 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or the “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced that it will hold a conference call with investors and analysts on Thursday, May 7, 2026 at 8:00 a.m. US Eastern Daylight Time and 8:00 p.m. Taiwan Time to discuss the Company’s first quarter 2026 financial results. HIMAX TECHNOLOGIES, INC. FIRST QUARTER 2026 EARNINGS CONFERENCE CALLDATE: Thursday, May 7, 2026TIME: U.S. 8:00 a.m. EDT  Taiwan 8:00 p.m.     Live Webcast (Video and Audio): https://www.zucast.com/webcast/VEYCPnbP Toll Free Dial-in Number (Audio Only):  Hong Kong 2112-1444  Taiwan 0080-119-6666  Australia 1-800-015-763  Canada 1-877-252-8508  China (1) 4008-423-888  China...

Continue reading

Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter

Strong growth in February/March following January seasonality Net revenue approaches US$100M since launch NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced Ryoncil® (remestemcel-L-rknd) net sales were US$30.3 million for the quarter ended March 31, 2026.1 Strong sales in February and March offset holiday seasonality in January. Revenue generated during this first year of Ryoncil® launch approaches US$100 million. Ryoncil® revenue strengthens Mesoblast’s balance sheet and supports label extension and late-stage blockbuster programs. Ryoncil® is the first mesenchymal stromal cell (MSC) product approved by the U.S. Food and Drug Administration (FDA) for any indication and is the only FDA-approved product...

Continue reading

HII Teams with GrayMatter Robotics to Integrate Physical AI into Manned and Unmanned Shipbuilding

CARSON, Calif., April 06, 2026 (GLOBE NEWSWIRE) — HII (NYSE: HII) and GrayMatter Robotics (GMR) signed a memorandum of understanding (MOU) today to explore the integration of GMR’s Physical AI into shipbuilding operations that could accelerate throughput, strengthen the maritime industrial base, and augment the shipbuilding workforce. This will include bringing autonomous surface preparation, coating, and inspection technologies into shipbuilding. The MOU signing ceremony took place at GrayMatter Robotics’ headquarters and was attended by Eric Chewning, HII’s executive vice president of maritime systems and corporate strategy, and Ariyan Kabir, GrayMatter Robotics CEO and co-founder. “We are in the midst of an American shipbuilding renaissance and we are extremely excited to partner with GrayMatter Robotics to explore incorporating...

Continue reading

Atlas Energy Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Operations and Filing of Its 2025 AIF

CALGARY, Alberta, April 06, 2026 (GLOBE NEWSWIRE) — Atlas Energy Corp. (“Atlas” or the “Company”) (TSXV: ATLE), a TSXV Sandbox issuer, is pleased to announce its financial and operating results for the three months and year ended December 31, 2025, and filing of its Annual Information Form (“AIF”). Selected financial and operational information is outlined below and should be read with Atlas’ audited consolidated financial statements and management’s discussion and analysis (“MD&A”) as of December 31, 2025, which are available on the Company’s SEDAR+ profile at www.sedarplus.ca. “With a strong balance sheet, including approximately $27.5 million in cash and no debt as of December 31, 2025, and an experienced leadership team in place, Atlas is well positioned to execute on its growth strategy,” said Mark Hodgson, Atlas Energy’s...

Continue reading

Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement

MELBOURNE, Australia and INDIANAPOLIS, April 07, 2026 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) provides a market update on its commercial and operational performance for the quarter ended March 31, 2026 (Q1 2026). Q1 2026 HighlightsQ1 2026 unaudited Group revenue of US$230 million, up 11% quarter-over-quarter. FY 2026 revenue guidance of US$950 million to US$970 million is reaffirmed. Precision Medicine Q1 2026 unaudited revenue of US$186 million, up 16% quarter-over-quarter. Strong revenue growth in both Illuccix® and Gozellix® segments. ProstACT® Global Phase 3 study of TLX591-Tx prostate cancer therapy candidate: Part 1 lead-in met safety and dosimetry objectives, with no new safety signals observed1. TLX101-Px (brain cancer imaging candidate): New Drug Application (NDA) resubmitted...

Continue reading

FTI Consulting Adds Three Leading Mining and Resources Business Improvement Experts

SYDNEY, April 06, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointments of James Chapman, Steve Dyson and Franz Wentzel as Senior Managing Directors in its Australian Transformation practice, bringing their experience as former global heads of Big Four accounting firm mining practices to help clients realise their full value potential. The appointments of Mr. Chapman, Mr. Dyson and Mr. Wentzel continue the firm’s growth of its Transformation – Mining team, following the recent addition of Carrie Grimes as a Senior Managing Director. “FTI Consulting has always been about bringing together senior experts, with deep real-world experience, to work side-by-side with clients at critical times to help solve their most important issues,” said Mark Dewar, Australia Leader of FTI Consulting. “James, Steve...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.